In Silico Prediction and Bioactivity Evaluation of Chemical Ingredients Against Influenza A Virus From Isatis tinctoria L

Abstract

Influenza A virus (IAV) is one of the major causes of seasonal endemic diseases and unpredictable periodic pandemics. Due to the high mutation rate and drug resistance, it poses a persistent threat and challenge to public health. Isatis tinctoria L. (Banlangen, BLG), a traditional herbal medicine widely used in Asian countries, has been reported to possess strong efficacy on respiratory viruses, including IAV. However, its effective anti-IAV components and the mechanism of actions (MOAs) are not yet fully elucidated. In this study, we first summarized the chemical components and corresponding contents in BLG according to current available chemical analysis literature. We then presented a network-based in silico framework for identifying potential drug candidates against IAV from BLG. A total of 269 components in BLG were initially screened by drug-likeness and ADME (absorption, distribution, metabolism, and excretion) evaluation. Thereafter, network predictive models were built via the integration of compound–target networks and influenza virus–host proteins. We highlighted 23 compounds that possessed high potential as anti-influenza virus agents. Through experimental evaluation, six compounds, namely, eupatorin, dinatin, linarin, tryptanthrin, indirubin, and acacetin, exhibited good inhibitory activity against wild-type H1N1 and H3N2. Particularly, they also exerted significant effects on drug-resistant strains. Finally, we explored the anti-IAV MOAs of BLG and showcased the potential biological pathways by systems pharmacology analysis. In conclusion, this work provides important information on BLG regarding its use in the development of anti-IAV drugs, and the network-based prediction framework proposed here also offers a powerfulful strategy for the in silico identification of novel drug candidates from complex components of herbal medicine.

Mechanism of thymosin β4 in ameliorating liver fibrosis via the MAPK/NF‐κB pathway

“…[ 30 ] Blocking of the MAPK pathway is correlated with inhibited HSC proliferation. [ 56–58 ] Moreover, we added MAPK activator into Tβ4‐overexpressing TGF‐β1‐induced LX‐2 cells and observed elevated cell proliferation and migration. Tβ4 can suppress interleukin‐1β‐elicited HSC‐LX2 cell proliferation by regulating the NF‐κB pathway.…”

Systems pharmacology dissection of pharmacological mechanisms of Xiaochaihu decoction against human coronavirus

“…Systems pharmacology had been recentely developed in TMC studies, it provided a network perspective to explore the relationship between components and targets [ 21 ]. It has been shown that systems pharmacology gave an effective approaches to identify the bioactive compounds, predict the corresponding targets and elucidate the molecular mechanisms about how does TCM work on different diseases [ 22 , 23 ]. For instance, by using this strategy, it uncovered the mechanism of Huanglian-Wuzhuyu herb pair in treating nonalcoholic steatohepatitis and predicted active ingredients, it also explained mechanism of Lianhuaqingwen capsule in treating COVID-19 [ 24 , 25 ].…”

Chemical Distance Measurement and System Pharmacology Approach Uncover the Novel Protective Effects of Biotransformed Ginsenoside C-Mc against UVB-Irradiated Photoaging

“…Structure-based approaches such as molecular docking are always encumbered by the computing speed and the resolution of crystal structures [ 23 ]. Besides, network approach based on system pharmacology, which comprehensively considers the information of drug-target network and disease-related genes, provides new insights into the identification of active ingredients against disease [ 26 – 28 ]. Nevertheless, as the object of this study is rare ginsenosides, most of which remain nearly unknown for the information of interacted targets.…”